PDCD1 and melanoma: IFN‐γ from PD‐1‐expressing NK cells then modulated tumor PD‐L1 expression, creating a self‐sustaining cycle that restored NK cytotoxicity and checkpoint inhibitor efficacy in refractory melanoma.